Talisa
Abies webbiana Lindl. (syn. Abies spectabilis (D. Don) Mirb.)
Talisa (Abies webbiana Lindl. (syn. Abies spectabilis (D. Don) Mirb.)) is a plant used in Ayurveda, from the Pinaceae family. Not listed in WHO monographs; recognized in Ayurvedic Pharmacopoeia of India; key ingredient in classical formulation Talisadi Churna.
| Botanical name | Abies webbiana Lindl. (syn. Abies spectabilis (D. Don) Mirb.) |
|---|---|
| Currently accepted name | Abies spectabilis (D.Don) Mirb. — the name above is treated as a synonym by GBIF; both are in use |
| Family | Pinaceae · other entries in this family |
| Order | Pinales |
| Pharmacopoeia status | Not listed in WHO monographs; recognized in Ayurvedic Pharmacopoeia of India; key ingredient in classical formulation Talisadi Churna |
| Taxon identifiers | GBIF 2685620 · Wikidata Q50826380 |
Names and identification
| Language | Name |
|---|---|
| English | Talisa |
| Latin/Botanical | Abies webbiana Lindl. (syn. Abies spectabilis (D. Don) Mirb.) |
Key Phytochemical Constituents
- 1,4’-methoxyphenyl-aziridine (alkaloid)
- Abiesin (biflavonoid)
- Essential oils (alpha-pinene, beta-pinene, limonene)
- Flavonoids
- Diterpenes
- Steroids (beta-sitosterol)
- Terpenes
- Phenols
- Tannins
- Saponins and quinones
How does it work?
- Bronchodilatory mechanism through calcium channel antagonism causing relaxation of bronchial smooth muscle, combined with anti-inflammatory reduction of airway hyperreactivity
- Antispasmodic action through inhibition of smooth muscle contraction via calcium channel blocking, supporting both respiratory and gastrointestinal applications
- Anti-platelet mechanism through inhibition of thromboxane synthesis and modulation of platelet aggregation pathways
Which traditional uses are supported by research?
- Bronchodilator and antitussive activity validated through pharmacological studies showing calcium channel-mediated smooth muscle relaxation, confirming use in Kasa (cough) and Shwasa (asthma)
- Anti-inflammatory activity validated through in vivo models, supporting traditional use in respiratory inflammation
- Antipyretic activity supported by preclinical evidence, confirming traditional use in Jwara (fever)
What do recent clinical trials show?
- Yasin M, Hussain Janbaz K, Imran I and others 2014. Pharmacological studies on the antispasmodic, bronchodilator and anti-platelet activities of Abies webbiana. Phytotherapy research : PTR. PMID 24395464 · doi:10.1002/ptr.5112
Demonstrated significant antispasmodic and bronchodilator activity supporting respiratory applications, along with anti-platelet effects mediated through calcium channel inhibition.
2 further claims previously listed here could not be traced to a published paper and have been removed. An absence here means we could not identify the source, not that no work exists.
Recent safety updates
- Traditionally used at recommended Ayurvedic doses (1-3g powder, 50-100ml decoction) with no significant adverse effects documented; commonly used in respiratory formulations like Talisadi Churna
- Potential for adulteration with Taxus baccata (yew), which contains toxic taxine alkaloids; proper botanical authentication is critical for safety
What is it made of?
Key Active Markers
- Limonene
- Flavonoids
- Diterpenes
- Steroids
- Sitosterol
- Tannins
- Saponins
- Abiesin
Analytical Methods: HPLC fingerprinting, TLC (identity), LC-MS/MS (marker quantification)
Dosage forms and preparation
Dosage Forms: Churna (powder), Kwatha (decoction), Vati (tablet), Capsule, Syrup, Avaleha (confection)
Standard Dosage: 1-3 g of powder twice daily; 50-100 mL decoction twice daily
Bioavailability: Moderate oral bioavailability; volatile terpenes (alpha-pinene, limonene) are rapidly absorbed from the GI tract but undergo significant first-pass hepatic metabolism. Co-administration with piperine or lipid-based carriers can enhance systemic availability of non-volatile terpenoids by 30-40%.
Optimal Timing: After meals with warm water or honey for respiratory conditions; morning and evening administration recommended
Standardized Extract: Standardized to minimum 0.5% v/w total essential oil (by hydrodistillation, Ph. Eur. method); hydroethanolic extract standardized to >2% total terpenoids (as alpha-pinene equivalent by GC-MS)
Shelf Life: Powder: 12 months in airtight container; Essential oil: 24 months; Tablets/Capsules: 24-36 months; Syrup: 18 months
Storage: Store in airtight, light-resistant containers at 15-25 deg C; protect from moisture and direct sunlight. Essential oil stored in amber glass bottles under nitrogen headspace.
Marker Compounds: alpha-Pinene, beta-Pinene, Limonene, Bornyl acetate, Camphene, delta-3-Carene, Myrcene
Extraction Methods
- Hydrodistillation for essential oil
- Hydroethanolic extraction (50-70% ethanol)
- Cold maceration for temperature-sensitive volatiles
- Supercritical CO2 extraction for terpenoid-rich fractions
- Steam distillation for essential oil
Synergistic Combinations
- Pippali (Piper longum) - enhances respiratory bioactivity
- Shunthi (Zingiber officinale) - synergistic bronchodilation
- Vasa (Adhatoda vasica) - complementary expectorant action
- Honey as anupana - enhances mucolytic delivery
Published research
Literature indexed in PubMed that concerns this subject, grouped by study type. A paper appearing here is a record of what has been published, not evidence that the subject works, and laboratory or animal results do not transfer to people. Study titles link to PubMed so you can read the source rather than take our word.
Laboratory and animal studies8
- 2024. In silico network pharmacology analysis and molecular docking validation of Swasa Kudori tablet for screening druggable phytoconstituents of asthmaAdvances in protein chemistry and structural biology. PMID 38220427 · doi:10.1016/bs.apcsb.2023.07.001
- 2015. Screening of Methanol Extract and Ethyl Acetate Fraction of Abies webbiana Lindl. for Neuropharmacological ActivitiesIndian journal of pharmaceutical sciences. PMID 26798167 · doi:10.4103/0250-474x.169039
- 2014. Pharmacological studies on the antispasmodic, bronchodilator and anti-platelet activities of Abies webbianaPhytotherapy research : PTR. PMID 24395464 · doi:10.1002/ptr.5112
- 2010. A new alkaloid isolated from Abies webbiana leafPharmacognosy research. PMID 21808564 · doi:10.4103/0974-8490.65516
- 2007. Antibacterial activity of Abies webbianaFitoterapia. PMID 17196767 · doi:10.1016/j.fitote.2006.09.025
- 2004. Synergistic effect of methanol extract of Abies webbiana leaves on sleeping time induced by standard sedatives in mice and anti-inflammatory activity of extracts in ratsJournal of ethnopharmacology. PMID 15234784 · doi:10.1016/j.jep.2004.04.014
- 2003. Antitussive activity of Abies webbiana Lindl. leaf extract against sulphur dioxide-induced cough reflex in micePhytotherapy research : PTR. PMID 13680827 · doi:10.1002/ptr.1263
- 1987. Glucosides from Abies webbianaPlanta medica. PMID 17268999 · doi:10.1055/s-2006-962678
Consult a qualified vaidya before acting on anything here. Ayurvedic practice is prescribed to a person, not to a condition: the same dravya is given, withheld or substituted depending on your constitution, your agni, the season and what else you are already taking. A page cannot know any of that. Self-prescribing from a reference is how the wrong preparation, the wrong dose or the wrong anupana gets used.
Educational reference only. Nothing on this page is medical advice, a diagnosis, or a recommendation to take anything. Traditional uses and research findings are reported as published, not as claims about what any product does. If you take prescribed medication, raise any interaction with the prescriber rather than acting on a page. See our editorial standards.